USPTO serial 90727451
SEACROSS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 14, 2023
- Examiner
- MCCARTHY, JOSEPH PATRICK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SEACROSS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Sichuan Huiyu Pharmaceutical Co., Ltd.
Neijiang, Sichuan, CN
Other trademarks owned by Sichuan Huiyu Pharmaceutical Co., Ltd.
Sichuan Huiyu Pharmaceutical Co., Ltd.
Neijiang, Sichuan, CN
Other trademarks owned by Sichuan Huiyu Pharmaceutical Co., Ltd.
Sichuan Huiyu Pharmaceutical Co., Ltd.
Neijiang, Sichuan, CN
Other trademarks owned by Sichuan Huiyu Pharmaceutical Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael J. Turgeon
Michael J. Turgeon VEDDER PRICE P.C.222 NORTH LASALLE STREETSUITE 2500CHICAGO, IL 60601Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical contraceptives; drugs for medical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; bacterial preparations for medical and veterinary use; bouillons for bacteriological cultures; biochemical medicines, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; prepared Chinese medicine, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; antibiotics; diagnostic preparations for medical purposes; medicines for human purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; medicines for dental purposes; chemical preparations for pharmaceutical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; chemical preparations for pharmaceutical purposes, namely, contrast agents; chemical preparations for pharmaceutical purposes, namely, antidote; syrups for pharmaceutical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; capsules for medicines, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; pharmaceutical preparations, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; chemico-pharmaceutical preparations, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; collyrium; biological preparations for medical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; lotions for pharmaceutical purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; medicinal tea; vaccines; food for babies; dietetic substances being fatty milk, omega-3 fish oil, amino acids, glucose, electrolytes, proteins, fats, carbohydrates, vitamins, trace elements, dietary fiber, and unsaturated fatty acids, all adapted for medical use; nutritional supplements; air purifying preparations; protein supplements for animals; medicines for veterinary purposes, namely, for antineoplastic, anti-cancerous, anti-infective purposes, for nervous system, digestive system, for cardiovascular and cerebrovascular purposes, for respiratory system, for anesthesia, endocrine and metabolic, slimming and lipid-dissolving purposes, for urogenital system, blood and hematopoietic system and immune system; pesticides; dressings, medical; dental lacquer | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sichuan Huiyu Pharmaceutical Co., Ltd.
- Other trademarks owned by Sichuan Huiyu Pharmaceutical Co., Ltd.
- Other trademarks owned by Sichuan Huiyu Pharmaceutical Co., Ltd.
- Other trademarks in Class 005
- Similar marks named SEACROSS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 14, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 14, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 29, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 29, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 9, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 26, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Oct 21, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Oct 17, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 26, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 26, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 26, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 7, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 2, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 18, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 25, 2021 | NWAP | NEW APPLICATION ENTERED | — |